Telix Pharmaceuticals Limited (TLX)

Telix Pharmaceuticals Revenue

Telix Pharmaceuticals had revenue of 188.96M AUD in the quarter ending June 30, 2024, with 58.05% growth. This brings the company's revenue in the last twelve months to 645.68M, up 80.92% year-over-year. In the year 2023, Telix Pharmaceuticals had annual revenue of 502.55M with 213.90% growth.

• Revenue (ttm): 645.68M AUD
• Revenue Growth: +80.92%
• P/S Ratio: n/a
• Revenue / Employee: 1,555,848 AUD
• Employees: 415
• Market Cap: 5.63B undefined

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2023	502.55M	342.45M	213.90%
Dec 31, 2022	160.10M	152.50M	2,007.64%
Dec 31, 2021	7.60M	2.38M	45.71%
Dec 31, 2020	5.21M	1.73M	49.58%
Dec 31, 2019	3.49M	3.29M	1,687.18%

Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.